Ivan Shishkin

Dr. Ivan Shishkin

Higher School of Medicine, Ualikhanov University, Kökshetaū, Aqmola, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
NINurbek Igissin
Nurbek Igissin
SDSergey Dyakov
Sergey Dyakov
ZTZhansaya Telmanova
Zhansaya Telmanova
IKIndira Kudaibergenova
Indira Kudaibergenova
SASerik Ayaganov
Serik Ayaganov
ZBZarina Bilyalova
Zarina Bilyalova
Objective: The aim is to analyze the incidence of kidney cancer over a 15-year period, considering factors such as stage, age, sex, and morphological verification in the regional context in Kazakhstan. Methods: The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Results: Among the meticulously documented 15,277 cases, a conspicuous male predominance was noted, comprising 53.7% of cases compared to 46.3% in females, with peak incidences observed within the 50-69 age cohorts. The average age at diagnosis exhibited a progressive rise over the study period, with discernible variations observed in age-specific incidence rates, particularly pronounced within the 60-84 age brackets. Noteworthy temporal trends indicated a consistent uptick in crude incidence rates, with distinct regional disparities manifesting higher rates in northern regions relative to their southern and western counterparts. Stratification by cancer stage unveiled a significant surge in stages I-II cases alongside a concomitant decrement in stage III incidences, complemented by reductions in stage IV occurrences and instances of unspecified disease stages. Morphological verification rates displayed regional variations, with an overarching ascending trajectory across most regions, albeit exceptions noted, notably in the Kyzylorda region. Conclusion: Our study identified a rise in kidney cancer incidence in Kazakhstan, likely reflecting global trends driven by increased risk factor exposure and incidental imaging findings. Regional disparities and varied stage distributions highlight the complexity of kidney cancer epidemiology. Despite advancements in early detection, delayed diagnosis persists, necessitating improved surveillance and diagnostic practices.

1 May 2024 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
NINurbek Igissin
Nurbek Igissin
DODidar Orazbayev
Didar Orazbayev
ZTZhansaya Telmanova
Zhansaya Telmanova
IKIndira Kudaibergenova
Indira Kudaibergenova
NMNiyazbek Mamatov
Niyazbek Mamatov
KKKarina Kozhakhmet
Karina Kozhakhmet
Objective: The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan. Methods: The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Results: Between 2005 and 2019, 13,510 cases of LC were documented, comprising 59.3% males and 40.7% females. Most diagnoses were seen in age groups 55-59 years (13.3%) to 75-79 years (11.7%). LC patients’ average age increased from 63.6 to 64.5 years. Incidence rates per 100,000 peaked at ages 65-69 years (35.1±1.0) and 70-74 years (43.3±1.0). LC incidence notably rose in the 70-74 years age group (APC=+0.89), contrasting with declining trends in younger age groups. Regional incidence variations revealed diverse patterns, mostly demonstrating unimodal increases, and some regions displaying bimodal growth. The age-standardized incidence rate was 5.7±0.1 per 100,000, declining from 2005 to 2012 (APC: −3.93), then rising until 2019 (APC: +1.13). Gender-specific standardized rates showed varied trends. Analyses of standardized indicators indicated declining trends in most regions but increased values in specific areas. Thematic maps classified incidence rates based on standardized indicators: low (up to 5.22), average (5.22 to 7.11), high (above 7.11 per 100,000 for the entire population). Conclusion: The study on liver cancer in Kazakhstan reveals marked gender and age differences. The standardized incidence rate among men was twofold greater than that among women. A distinct rise in cases was noted among individuals aged 70-74 years. Regional variations in incidence were evident. These findings emphasize the necessity for focused research to comprehend the causes behind these differences, enabling customized interventions for Kazakhstan’s population.

31 March 2026 in Euroasian Health Journal
Verified
Journal Article
Closed access
NMN. Murzagulov
N. Murzagulov
ZTZ. Telmanova
Z. Telmanova
ISI. Shishkin
I. Shishkin
KRK. Rustemova
K. Rustemova
NIN. Igissin
N. Igissin
Diseases of the large intestine continue to make a significant contribution to population morbidity and mortality, which determines their high medical and social importance. Since the beginning of the 21st century, an increase in the prevalence of colorectal pathology has been observed, along with a shift in the age structure of patients toward younger groups, which highlights the relevance of analysing factors influencing the development of these diseases and approaches to their prevention. The aim of this review was to summarise and systematise current scientific evidence on risk determinants and strategies for reducing the burden of major diseases of the large intestine. An analysis of 52 publications was conducted, including systematic reviews, meta-analyses, large cohort studies, and randomised controlled trials retrieved from PubMed, Scopus, Web of Science, and Google Scholar databases. The review included studies published between 1990 and 2025, with 53.8% of the sources dated from 2020 to 2025. The literature analysis demonstrated that dietary patterns, excess body weight, low physical activity, smoking, and alcohol consumption play a leading role in the development of large intestinal diseases. Alterations in gut microbiota composition and chronic inflammation are considered key pathogenic mechanisms. A reduction in disease incidence and mortality has been confirmed for screening strategies based on endoscopic and noninvasive methods, as well as for selected pharmacological and technological approaches, including computerassisted endoscopic systems. The findings of this review may be applied in clinical practice, planning of screening programs, and development of prevention-oriented interventions within public health systems Заболевания толстого кишечника продолжают вносить значительный вклад в структуру заболеваемости и смертности населения, что обусловливает их высокую медико-социальную значимость. С начала XXI века отмечается рост распространённости колоректальной патологии, а также смещение возрастной структуры пациентов в сторону более молодых групп, что усиливает актуальность анализа факторов, влияющих на развитие данных заболеваний, и подходов к их предупреждению. Целью настоящей обзорной работы было обобщение и систематизация современных научных данных о детерминантах риска и мерах снижения бремени основных заболеваний толстого кишечника. Проведён анализ 52 публикаций, включающих систематические обзоры, метаанализы, крупные когортные и рандомизированные исследования, представленные в базах PubMed, Scopus, Web of Science и Google Scholar. В обзор включены работы, опубликованные в период с 1990 по 2025 годы, при этом 53,8% источников относятся к периоду 2020-2025 годов. Анализ литературы показал, что ведущую роль в формировании заболеваний толстого кишечника играют особенности питания, избыточная масса тела, низкий уровень физической активности, курение и злоупотребление алкоголем. Существенное значение имеют нарушения состава кишечной микробиоты и хроническое воспаление, рассматриваемые как ключевые патогенетические механизмы. Эффективность снижения заболеваемости и смертности подтверждена для скрининговых стратегий, основанных на эндоскопических и неинвазивных методах, а также для отдельных медикаментозных и технологических подходов, включая системы компьютерной поддержки эндоскопии. Результаты обзора могут быть использованы при клиническом ведении пациентов, планировании программ скрининга и разработке профилактически ориентированных мероприятий в системе общественного здравоохранения Жоон ичегинин оорулары калктын оорулуулугу жана өлүм-житими түзүмүндө олуттуу орунду ээлеп, алардын жогорку медициналык жана социалдык маанисин шарттайт. XXI кылымдын башынан тартып колоректалдык патологиянын таралышынын өсүшү, ошондой эле бейтаптардын жаш курактык түзүмүнүн жаш топтор тарапка жылышы байкалган. Бул жагдайлар аталган оорулардын өнүгүшүнө таасир этүүчү факторлорду жана алардын алдын алуу жолдорун талдоонун актуалдуулугун күчөткөн. Бул обзордук иштин максаты жоон ичегинин негизги...

30 August 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
ZBZ.A. Bilyalova
Z.A. Bilyalova
NYN.Y. Yermek
N.Y. Yermek
ZTZh.B. Telmanova
Zh.B. Telmanova
ISI.YU. Shishkin
I.YU. Shishkin
GIG.S. Igissinova
G.S. Igissinova
NIN.S. Igissin
N.S. Igissin
Background. Regional analyses integrating prostate cancer incidence, stage at diagnosis, and mortality can identify epidemiological patterns that may be obscured by national estimates. Such evidence remains limited for Akmola Region. Objective. To characterize the age profile of prostate cancer and determine how incidence, diagnostic-stage composition, mortality changed in Akmola Region between 2005-2024. Materials and Methods. Twenty consecutive annual observations were assembled from Forms No. 7 and 35 of national cancer reporting system and from official estimates of the male resident population. For each calendar year, we derived population-based rates of newly diagnosed cases and prostate cancer deaths; incidence was additionally examined by age and stage at diagnosis. Log-linear Joinpoint models were fitted to the annual series, and temporal slopes were expressed as APC and, where applicable, AAPC, together with their 95% confidence intervals. Results. Registry returns contained 1,003 newly diagnosed cases and 413 deaths attributed to prostate cancer during the observation period. The standardized incidence series nearly doubled between the study endpoints, rising from 9.3 per 100,000 in 2005 to 19.2 in 2024; the model estimated an APC of 2.6% (p=0.002). Of all age strata, men aged 75-79 years had the highest mean annual incidence, at 189.5 per 100,000. For stages I-II, the incidence rate followed an upward trajectory (APC=3.3%; p=0.002), but these stages accounted for a progressively smaller share of all diagnoses, decreasing from 62.5% to 35.4%. A substantially steeper trajectory was observed for stage IV disease: its incidence rose from 1.4 to 10.6 per 100,000 (APC=9.8%; p<0.001), while its contribution to all registered cases expanded from 15.6% to 50.0%. Stage IV represented the largest diagnostic-stage category in 2022 and 2024. Although ASMR was lower at the end of follow-up than at baseline 5.6 versus 8.5 per 100,000 the fitted temporal slope did not differ statistically from zero (APC=−0.9%; p=0.616). Conclusions. Akmola Region experienced a clear rise in newly detected prostate cancer, with the steepest increase occurring in stage IV disease. Mortality showed no statistically reliable direction of change. The divergence between these indicators supports closer examination of regional diagnostic pathways, stage-recording practices, and subsequent population-based outcomes. Актуальность. Региональный анализ заболеваемости раком предстательной железы, стадийной структуры и смертности позволяет выявить эпидемиологические особенности, которые могут быть скрыты при оценке общенациональных показателей. Комплексные данные по Акмолинской области остаются ограниченными. Цель. Оценить возрастные особенности и многолетние тенденции заболеваемости, стадийной структуры при установлении диагноза и смертности от рака предстательной железы в Акмолинской области за 2005-2024 годы. Материалы и методы. Для 2005-2024 годов был сформирован региональный временной ряд, включавший 20 последовательных годовых наблюдений, полученных из сводных форм №7 и №35 национального канцер-регистра Республики Казахстан и официальной статистики мужского населения. В каждом календарном году зарегистрированное число новых случаев и смертей соотносили с соответствующей численностью мужского населения и выражали на 100 000 человек. Расчеты выполняли для всех возрастов без возрастной корректировки, для отдельных возрастных групп и с учетом различий в возрастной структуре населения. К годовым рядам применяли лог-линейные модели Joinpoint: направление и скорость изменения внутри каждого сегмента характеризовали посредством APC, а обобщенную динамику интервала с несколькими сегментами – посредством AAPC. Для обеих оценок приводили 95% доверительные интервалы. Результаты. Зарегистрировано 1 003 случая рака предстательной железы и 413 смертей от данного заболевания. Стандартизованный показатель заболеваемости увеличился с 9,3 на 100 000 мужчин в 2005 году до 19,2 в 2024 году (APC=2,6%; 95% ДИ: 1,0-4,7; p=0,002). Максимальный среднегодовой повозрастной показатель заболеваемости отмечен среди мужчин 75-79 лет – 189,5 на 100 000. Несмотря на увеличение заболеваемости опухолями I-II стадии (APC=3,3%; p=0,002), их доля снизилась с 62,5% до 35,4%. Заболеваемость опухолями IV стадии увеличилась с 1,4 до 10,6 на 100 000 мужчин (APC=9,8%; p<0,001), а их доля возросла с 15,6% до 50,0% и была наибольшей в 2022 и...

30 October 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
NIN.S. Igissin
N.S. Igissin
ZTZh.B. Telmanova
Zh.B. Telmanova
NMN.A. Murzagulov
N.A. Murzagulov
GIG.S. Igissinova
G.S. Igissinova
DTD.K. Turebaev
D.K. Turebaev
ZBZ.A. Bilyalova
Z.A. Bilyalova
Introduction. Rectal cancer constitutes a sizable share of the oncology workload. Reliable interpretation of long‑term trends requires disentangling demographic forces from genuine changes in age‑specific risk, particularly during program roll‑out and the service disruptions associated with COVID‑19. The aim of the study is to quantify the separate contributions of population size, age structure, and age‑specific risk to rectal cancer incidence in Kazakhstan, 2005–2024, partitioned into five phases: pre‑screening (2005–2010), early roll‑out (2011–2013), program stabilization (2014–2019), pandemic impact (2020–2021), and post‑pandemic recovery (2022–2024). Material and research methods. A population‑based retrospective study using the Ministry of Health Form No. 7 (ICD‑10: C19–C21). We applied a seven‑term decomposition with demographic components and risk‑related terms; here, “risk” denotes residual change in age‑specific incidence after removing demographic effects. Results. Over 2005–2024, 28,368 new cases were registered. The crude incidence rate (CR) increased from 7.80 to 9.13 per 100,000 (+1.34). Decomposition of CR yielded: ∑ΔA=+1.42, ∑ΔR=−0.05, ∑ΔRA=−0.03 (per 100,000), indicating a rise driven by population ageing with stable or slightly declining age-specific risks. By phase: 2005–2010 – declines in CR and ASR due to ΔR0); 2014–2019 – CR rises while ASR falls, increase fully demographic; 2020–2021 – compensatory increase versus 2020, yet 2021 below 2019; 2022–2024 – CR rises with a “flat” ASR, contribution almost exclusively demographic. Age profile stable: ages 50–79 ≈80.7% of registrations. Conclusions. The upward drift in crude incidence is primarily demographic, while true risk variation is phase‑bound and program‑linked. Policy should prioritize resilient early‑detection pathways, surge capacity for endoscopy, and routine component‑based surveillance focused on ages 50–79. Введение. Рак прямой кишки вносит существенный вклад в суммарную нагрузку онкологических заболеваний. Корректная интерпретация временных рядов требует раздельной оценки демографических эффектов и подлинной динамики возраст‑специфического риска, особенно при развёртывании организованного скрининга и структурных ограничениях периода COVID‑19. Цель исследования: количественно разложить вклад демографических факторов (численность населения и возрастная структура) и возраст‑специфического риска в изменение заболеваемости раком прямой кишки в Казахстане в 2005-2024 гг., с анализом пяти фаз: доскрининговый этап (2005-2010), раннее развёртывание (2011-2013), стабилизация программы (2014-2019), пандемическое воздействие (2020-2021) и постпандемическое восстановление (2022-2024). Материалы и методы. Популяционное ретроспективное исследование на основе официальной отчётной формы № 7 Минздрава РК (МКБ‑10: C19–C21). Для оценки динамики числа случаев применено компонентное разложение с выделением семи факторов. Результаты. За 2005–2024 гг. зарегистрировано 28 368 первичных случаев. Грубый показатель заболеваемости (ГП) вырос с 7,80 до 9,13 на 100 000 (+1,34). Декомпозиция ГП: суммарно ∑ΔA=+1,42, ∑ΔR=−0,05, ∑ΔRA=−0,03 (на 100 000) – прирост обусловлен старением населения при стабильных/слегка снижающихся возрастных рисках. По этапам: 2005–2010 – снижение ГП и ВСП за счёт ΔR0); 2014–2019 – рост ГП при снижении ВСП, прирост полностью демографический; 2020–2021 – компенсаторный рост относительно 2020 г., но уровень 2021 г. ниже 2019 г.; 2022–2024 – рост ГП при «плоском» ВСП, вклад почти исключительно демографический. Возрастной вклад устойчив: 50–79 лет ≈80,7% всех регистраций. Выводы. Долгосрочный рост заболеваемости определяется главным образом старением и увеличением численности населения; изменения «истинного» риска носят кратковременный характер и совпадают с программными и организационными сдвигами. Рекомендуется внедрять устойчивое компонентное наблюдение, планировать резерв мощности эндоскопии и фокусировать профилактику на когортах 50–79 лет. Кіріспе. Тік ішек қатерлі ісігі онкологиялық қызметтің елеулі бөлігін құрайды. Ұзақ мерзімді динамиканы дұрыс түсіндіру үшін демографиялық әсерлерді жас‑ерекшелік...

23 October 2026 in Astana Medical Journal
Verified
Journal Article
Closed access
NMNurymzhan Murzagulov
Nurymzhan Murzagulov
ZTZhansaya Telmanova
Zhansaya Telmanova
BABolat Abishev
Bolat Abishev
RMRustem Moldagali
Rustem Moldagali
BZBanurzhan Zhangalov
Banurzhan Zhangalov
NINurbek Igissin
Nurbek Igissin
Relevance. Colorectal cancer, Crohn’s disease, ulcerative colitis, and colonic polyposis are major public health problems. These diseases reduce quality of life, increase disability and healthcare costs, and affect screening policy. Population aging, urbanization, and lifestyle changes have altered their incidence and age distribution in many countries. This burden makes their epidemiological assessment particularly important for public health planning, prevention, early detection, and organization of appropriate healthcare services. Objective. To summarize recent evidence on the epidemiology, risk factors, diagnosis, and prevention of major colon diseases worldwide and in Kazakhstan, with attention to regional differences and gaps in knowledge. Evidence was considered globally and nationally to provide comparative perspective. Methodology. A structured narrative literature review was conducted using PubMed, Scopus, eLibrary, and Google Scholar. The initial literature search was performed from June to August 2025, and the evidence base was subsequently updated to include relevant publications available through October 2026. The review primarily covered literature published between 2015 and 2026, with earlier landmark studies included where appropriate. Eligible sources comprised original research articles, systematic reviews, meta-analyses, clinical guidelines, authoritative reference materials, and official epidemiological and statistical reports. A total of 89 sources were included in the final narrative synthesis. Results. Colorectal cancer remains a major contributor to cancer incidence and mortality worldwide and in Kazakhstan. According to GLOBOCAN 2024 estimates, colorectal cancer accounted for 3,598 new cases (12.1% of all estimated cancer cases) in Kazakhstan. National statistical data demonstrated regional differences in colorectal cancer incidence and the continued occurrence of advanced-stage disease. Colorectal carcinogenesis involves chromosomal instability, microsatellite instability, and serrated neoplasia pathways, while hereditary syndromes contribute to increased individual risk. Advances in image-enhanced endoscopy, artificial intelligence-assisted colonoscopy, capsule endoscopy, and molecular testing offer additional diagnostic opportunities. However, gaps remain in population-based epidemiological data on inflammatory bowel diseases and colonic polyposis in Kazakhstan. Conclusions. The reviewed evidence highlights the importance of risk-factor modification, organized colorectal cancer screening, early detection and removal of precancerous lesions, and risk-adapted surveillance of individuals with hereditary predisposition. For Kazakhstan, priorities include improving screening quality, strengthening national cancer registration and epidemiological monitoring, expanding access to diagnostic services, and developing population-based research on inflammatory bowel diseases and colonic polyposis. Modern diagnostic technologies should complement established clinical pathways rather than replace colonoscopy and histological examination. Keywords: colorectal neoplasms, Crohn disease, ulcerative colitis, intestinal polyposis, epidemiology, Kazakhstan.